Treatment of AL amyloidosis with high dose therapy and autologous stem cell transplantation

被引:1
|
作者
Dimopoulos, Meletios A. [1 ]
机构
[1] Univ Athens, Sch Med, Dept Clin Therapeut, GR-11527 Athens, Greece
关键词
D O I
10.1080/10428190600647509
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:963 / 964
页数:2
相关论文
共 50 条
  • [1] Treatment of AL amyloidosis with tandem cycles of high dose melphalan and autologous stem cell transplantation
    Sanchorawala, V
    Wright, DG
    Quillen, K
    Kunz, R
    Finn, KT
    Malek, K
    Falk, RH
    Berk, JL
    Dember, LM
    Skinner, M
    Seldin, DC
    [J]. BLOOD, 2003, 102 (11) : 117A - 117A
  • [2] High dose intravenous melphalan and autologous stem cell transplantation for the treatment of AL amyloidosis: Morbidity and mortality
    Wright, DG
    Sanchorawala, V
    Taper, J
    Seldin, DC
    Falk, RH
    Dember, L
    Berk, J
    Finn, K
    Quillen, K
    Skinner, M
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 : 60 - 60
  • [3] An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis
    V Sanchorawala
    DG Wright
    DC Seldin
    LM Dember
    K Finn
    RH Falk
    J Berk
    K Quillen
    M Skinner
    [J]. Bone Marrow Transplantation, 2001, 28 : 637 - 642
  • [4] An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis
    Sanchorawala, V
    Wright, DG
    Seldin, DC
    Dember, LM
    Finn, K
    Falk, RH
    Berk, J
    Quillen, K
    Skinner, M
    [J]. BONE MARROW TRANSPLANTATION, 2001, 28 (07) : 637 - 642
  • [5] Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation
    Osamu Yamazaki
    Yoshifumi Ubara
    Tatsuya Suwabe
    Shohei Nakanishi
    Junichi Hoshino
    Naoki Sawa
    Noriko Hayami
    Masayuki Yamanouchi
    Fumi Takemoto
    Takaichi Kenmei
    Kazuhiro Masuoka
    Kenichi Oohashi
    [J]. Clinical and Experimental Nephrology, 2009, 13 : 522 - 525
  • [6] Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation
    Yamazaki, Osamu
    Ubara, Yoshifumi
    Suwabe, Tatsuya
    Nakanishi, Shohei
    Hoshino, Junichi
    Sawa, Naoki
    Hayami, Noriko
    Yamanouchi, Masayuki
    Takemoto, Fumi
    Kenmei, Takaichi
    Masuoka, Kazuhiro
    Oohashi, Kenichi
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2009, 13 (05) : 522 - 525
  • [7] Autologous stem cell transplantation for AL amyloidosis: a standard therapy?
    P Moreau
    [J]. Leukemia, 1999, 13 : 1929 - 1931
  • [8] Autologous stem cell transplantation for AL amyloidosis: a standard therapy?
    Moreau, P
    [J]. LEUKEMIA, 1999, 13 (12) : 1929 - 1931
  • [9] HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AL AMYLOIDOSIS PATIENTS
    Michael, M.
    Kastritis, E.
    Delimbassi, S.
    Kyrtsonis, M. C.
    Papadimetriou, C.
    Apostolides, I.
    Panayiotidis, P.
    Harhalakis, N.
    Pangalis, G.
    Dimopoulos, M. A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 469 - 470
  • [10] High Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis
    Sanchorawala, Vaishali
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (06) : 1131 - +